MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$333,000
-12.1%
79,942
+1.0%
0.00%
Q4 2021$379,000
-12.1%
79,123
-2.0%
0.00%
Q3 2021$431,000
+2.9%
80,725
-1.3%
0.00%
Q2 2021$419,000
-23.3%
81,784
+0.9%
0.00%
Q1 2021$546,000
+31.9%
81,084
-10.6%
0.00%
Q4 2020$414,000
-71.9%
90,695
+0.8%
0.00%
-100.0%
Q2 2018$1,475,00089,9330.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders